MATINAS BIOPHARMA HOLDINGS, INC. Accrued Liabilities, Current
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Accrued Liabilities, Current of $504.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Accrued Liabilities, Current $504.00K.
- 2026-03-31: Accrued Liabilities, Current $694.00K.
- 2025-12-31: Accrued Liabilities, Current $452.00K.
- 2025-09-30: Accrued Liabilities, Current $564.00K.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $504.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $694.00K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $452.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $564.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $795.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.18M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.80M 10-K · filed 2026-03-31 | $1.80M 10-K · filed 2025-04-15 |
| 2024-09-30 | $1.04M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $1.44M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $839.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.45M 10-K · filed 2025-04-15 | |
| 2023-09-30 | $1.76M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $1.37M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $791.00K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $3.10M 10-K · filed 2024-03-27 | |
| 2022-09-30 | $3.70M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $4.29M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.84M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $2.85M 10-K · filed 2023-03-15 | $2.85M 10-K · filed 2022-03-08 |
| 2021-09-30 | $2.89M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $2.76M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $1.41M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $2.80M 10-K/A · filed 2022-03-11 | |
| 2020-09-30 | $2.02M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $1.43M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $1.11M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.94M 10-K · filed 2021-03-29 | |
| 2019-09-30 | $1.46M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $1.27M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $1.01M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $1.09M 10-K · filed 2020-03-09 | |
| 2018-09-30 | $758.34K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $939.60K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $462.23K 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $959.15K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $753.76K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $731.67K 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $471.50K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $829.72K 10-K · filed 2018-03-16 | |
| 2016-09-30 | $941.33K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $845.06K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $689.24K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $610.21K 10-K · filed 2017-03-31 | |
| 2015-09-30 | $549.99K 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $339.83K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $780.84K 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $802.75K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $764.75K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $547.33K 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $386.48K 10-Q · filed 2014-06-06 | |
| 2013-12-31 | $462.20K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |